Skip to main content

The risk identified from clinical trials

  • Chapter
Medicines and Risk/Benefit Decisions

Part of the book series: CMR Workshop Series ((CMRWS))

  • 34 Accesses

Abstract

Toxicology is not a black art but a science which belongs to the general group of the pharmacological sciences. As such it must be analysed in terms of factors such as dose, route of administration, duration of exposure and individual (usually genetic) predisposition. The reason that toxicology, both in animals and in man, often does appear to be more of an art than a science is that prescribers, regulators and industrialists usually have to make their decisions on the basis of inadequate data. They do so in the name, often quite reasonably, of trying to minimize risk.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1978). Br. Heart J. 40, 1069–18

    Google Scholar 

  2. (1985). Br. Med. J. MRC trial of treatment of mild hypertension: principal result. Medical Research Council Working Party. 291, 97–97

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 MTP Press Limited

About this chapter

Cite this chapter

Dollery, C.T. (1987). The risk identified from clinical trials. In: Walker, S.R., Asscher, A.W. (eds) Medicines and Risk/Benefit Decisions. CMR Workshop Series. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3221-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3221-0_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7946-4

  • Online ISBN: 978-94-009-3221-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics